Your browser doesn't support javascript.
loading
Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals.
Shields, Carol L; Dalvin, Lauren A; Chang, Michael; Mazloumi, Mehdi; Fortin, Patricia; McGarrey, Mark; Martin, Andrei; Yaghy, Antonio; Yang, Xiaolu; Vichitvejpaisal, Pornpattana; Mashayekhi, Arman; Shields, Jerry A.
Afiliación
  • Shields CL; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Dalvin LA; Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.
  • Chang M; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Mazloumi M; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Fortin P; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • McGarrey M; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Martin A; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Yaghy A; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Yang X; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Vichitvejpaisal P; Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand.
  • Mashayekhi A; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Shields JA; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
JAMA Ophthalmol ; 138(2): 136-146, 2020 02 01.
Article en En | MEDLINE | ID: mdl-31830238
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Úvea / Agudeza Visual / Bevacizumab / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ophthalmol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Úvea / Agudeza Visual / Bevacizumab / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ophthalmol Año: 2020 Tipo del documento: Article